Results 111 to 120 of about 23,536 (264)

Top 10 NNRTI-RAMs found in patients who failed either the NVP- or EFV-based regimen.

open access: yes, 2016
Top 10 NNRTI-RAMs found in patients who failed either the NVP- or EFV-based regimen.
Anchalee Avihingsanon (340691)   +6 more
core   +1 more source

Tight binding NNRTi affect the late stages of HIV-1 replication

open access: yes, 2005
Tight binding NNRTi affect the late stages of HIV-1 ...
N Sluis-Cremer (13717387)   +4 more
core   +1 more source

Design, Synthesis, and Preclinical Evaluations of Novel 4-Substituted 1,5-Diarylanilines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Drug Candidates

open access: yesJournal of Medicinal Chemistry, 2012
Twenty-one new 4-substituted diarylaniline compounds (DAANs) (Scheme 2, series 13, 14, and 15) were designed, synthesized, and evaluated against wild-type and drug resistant HIV-1 viral strains.
Lian-Qi Sun   +7 more
semanticscholar   +1 more source

Clearance of NNRTI resistance-associated mutations in the HIV-1 DNA reservoir with or without the presence of M184V mutation

open access: yes
Background Recent studies have shown progress in understanding the evolution of HIV antiretroviral resistance–associated mutations (RAMs) in the reservoir, particularly M184V, but data on non-nucleoside reverse transcriptase (RT ...
Karen Zafilaza   +12 more
core   +1 more source

Distribution of NNRTI (etravirine) secondary mutations in 112 specimens collected in Maputo and Beira in 2009.

open access: yes, 2013
Distribution of NNRTI (etravirine) secondary mutations in 112 specimens collected in Maputo and Beira in 2009.
Harriet Merks (160749)   +10 more
core   +1 more source

Distribution of NRTI (a) and NNRTI (b) resistance-associated mutations detected in the historical genotypic resistance tests of the patients.

open access: yes, 2015
NNRTI: non nucleoside reverse transcriptase inhibitors, NRTI: nucleoside reverse transcriptase inhibitors.
Benoit Visseaux (288245)   +10 more
core   +1 more source

Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis.

open access: yesPLoS ONE, 2016
BackgroundHIV transmitted drug resistance (TDR) remains at moderate level in Latin America and the Caribbean (LAC). However, different epidemiologic scenarios could influence national and sub-regional TDR levels and trends.Methods and findingsWe ...
Santiago Avila-Rios   +5 more
doaj   +1 more source

Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort

open access: yesBMC Women's Health, 2011
Background Information concerning lipid disturbances in HIV-infected women on antiretroviral therapy (ART) is scarce. The objective of the study is to describe the lipid profile in a large cohort of HIV-infected women on contemporary ART and analyse ...
Estrada Vicente   +25 more
doaj   +1 more source

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children

open access: yesAIDS Research and Therapy, 2011
BackgroundThere are limited data of immunologic and virologic failure in Asian HIV-infected children using non-nucleoside reverse transcriptase inhibitor (NNRTI)-based highly active antiretroviral therapy (HAART).
T. Bunupuradah   +11 more
semanticscholar   +1 more source

Activity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants

open access: yes, 2009
In this preliminary study we report the antiviral screening of triazolo[4,5-g]quinoline derivatives (compounds 1–6). 4,9-Dihydrotriazolo[4,5-g]quinoline-1-oxide (1) stood out as a new, small molecule endowed with a selective, promising activity in cell ...
Fermeglia, Maurizio   +20 more
core   +1 more source

Home - About - Disclaimer - Privacy